nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—forebrain—epilepsy syndrome	0.0152	0.154	CbGeAlD
Framycetin—CXCR4—telencephalon—epilepsy syndrome	0.014	0.141	CbGeAlD
Framycetin—Ulcerative keratitis—Pregabalin—epilepsy syndrome	0.0114	0.0405	CcSEcCtD
Framycetin—CXCR4—medulla oblongata—epilepsy syndrome	0.011	0.111	CbGeAlD
Framycetin—CXCR4—midbrain—epilepsy syndrome	0.0101	0.101	CbGeAlD
Framycetin—CXCR4—spinal cord—epilepsy syndrome	0.00982	0.099	CbGeAlD
Framycetin—CXCR4—head—epilepsy syndrome	0.00873	0.0879	CbGeAlD
Framycetin—CXCR4—nervous system—epilepsy syndrome	0.00828	0.0834	CbGeAlD
Framycetin—CXCR4—central nervous system—epilepsy syndrome	0.00797	0.0803	CbGeAlD
Framycetin—CXCR4—cerebellum—epilepsy syndrome	0.00779	0.0785	CbGeAlD
Framycetin—Impaired healing—Pregabalin—epilepsy syndrome	0.00665	0.0237	CcSEcCtD
Framycetin—CXCR4—brain—epilepsy syndrome	0.00633	0.0637	CbGeAlD
Framycetin—Glaucoma—Zonisamide—epilepsy syndrome	0.00602	0.0214	CcSEcCtD
Framycetin—Viral infection—Levetiracetam—epilepsy syndrome	0.00572	0.0204	CcSEcCtD
Framycetin—Viral infection—Vigabatrin—epilepsy syndrome	0.00538	0.0192	CcSEcCtD
Framycetin—Viral infection—Clonazepam—epilepsy syndrome	0.00483	0.0172	CcSEcCtD
Framycetin—Viral infection—Oxcarbazepine—epilepsy syndrome	0.00478	0.017	CcSEcCtD
Framycetin—Swelling—Midazolam—epilepsy syndrome	0.0043	0.0153	CcSEcCtD
Framycetin—Swelling—Diazepam—epilepsy syndrome	0.00394	0.014	CcSEcCtD
Framycetin—Glaucoma—Pregabalin—epilepsy syndrome	0.00382	0.0136	CcSEcCtD
Framycetin—Swelling—Clonazepam—epilepsy syndrome	0.00359	0.0128	CcSEcCtD
Framycetin—Viral infection—Valproic Acid—epilepsy syndrome	0.00352	0.0125	CcSEcCtD
Framycetin—Glaucoma—Gabapentin—epilepsy syndrome	0.0035	0.0125	CcSEcCtD
Framycetin—Swelling—Carbamazepine—epilepsy syndrome	0.00341	0.0121	CcSEcCtD
Framycetin—Viral infection—Pregabalin—epilepsy syndrome	0.00318	0.0113	CcSEcCtD
Framycetin—Erythema—Phenobarbital—epilepsy syndrome	0.00316	0.0112	CcSEcCtD
Framycetin—Glaucoma—Topiramate—epilepsy syndrome	0.00295	0.0105	CcSEcCtD
Framycetin—Viral infection—Gabapentin—epilepsy syndrome	0.00292	0.0104	CcSEcCtD
Framycetin—Erythema—Lacosamide—epilepsy syndrome	0.00291	0.0104	CcSEcCtD
Framycetin—Swelling—Valproic Acid—epilepsy syndrome	0.00262	0.00932	CcSEcCtD
Framycetin—Hypersensitivity—Amobarbital—epilepsy syndrome	0.00253	0.009	CcSEcCtD
Framycetin—Infection—Rufinamide—epilepsy syndrome	0.00251	0.00894	CcSEcCtD
Framycetin—Viral infection—Topiramate—epilepsy syndrome	0.00246	0.00874	CcSEcCtD
Framycetin—Erythema—Propofol—epilepsy syndrome	0.00234	0.00832	CcSEcCtD
Framycetin—Infection—Clobazam—epilepsy syndrome	0.00229	0.00815	CcSEcCtD
Framycetin—Erythema—Midazolam—epilepsy syndrome	0.00229	0.00814	CcSEcCtD
Framycetin—Vomiting—Amobarbital—epilepsy syndrome	0.00218	0.00777	CcSEcCtD
Framycetin—Swelling—Gabapentin—epilepsy syndrome	0.00217	0.00772	CcSEcCtD
Framycetin—Vomiting—Primidone—epilepsy syndrome	0.0021	0.00748	CcSEcCtD
Framycetin—Erythema—Diazepam—epilepsy syndrome	0.00209	0.00745	CcSEcCtD
Framycetin—Pruritus—Trimethadione—epilepsy syndrome	0.00206	0.00733	CcSEcCtD
Framycetin—Anaphylactic shock—Acetazolamide—epilepsy syndrome	0.00205	0.00731	CcSEcCtD
Framycetin—Nausea—Amobarbital—epilepsy syndrome	0.00204	0.00726	CcSEcCtD
Framycetin—Nausea—Primidone—epilepsy syndrome	0.00196	0.00699	CcSEcCtD
Framycetin—Anaphylactic shock—Propofol—epilepsy syndrome	0.00191	0.00679	CcSEcCtD
Framycetin—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.0019	0.00676	CcSEcCtD
Framycetin—Anaphylactic shock—Midazolam—epilepsy syndrome	0.00187	0.00664	CcSEcCtD
Framycetin—Hypersensitivity—Rufinamide—epilepsy syndrome	0.00186	0.00663	CcSEcCtD
Framycetin—Vomiting—Trimethadione—epilepsy syndrome	0.00185	0.00658	CcSEcCtD
Framycetin—Infection—Levetiracetam—epilepsy syndrome	0.00183	0.00652	CcSEcCtD
Framycetin—Erythema—Carbamazepine—epilepsy syndrome	0.00181	0.00645	CcSEcCtD
Framycetin—Pruritus—Rufinamide—epilepsy syndrome	0.00179	0.00637	CcSEcCtD
Framycetin—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.00178	0.00633	CcSEcCtD
Framycetin—Infection—Fosphenytoin—epilepsy syndrome	0.00177	0.00629	CcSEcCtD
Framycetin—Erythema—Lamotrigine—epilepsy syndrome	0.00175	0.00623	CcSEcCtD
Framycetin—Hypersensitivity—Lacosamide—epilepsy syndrome	0.00175	0.00623	CcSEcCtD
Framycetin—Diarrhoea—Rufinamide—epilepsy syndrome	0.00173	0.00616	CcSEcCtD
Framycetin—Nausea—Trimethadione—epilepsy syndrome	0.00173	0.00615	CcSEcCtD
Framycetin—Infection—Vigabatrin—epilepsy syndrome	0.00172	0.00613	CcSEcCtD
Framycetin—Anaphylactic shock—Diazepam—epilepsy syndrome	0.00171	0.00608	CcSEcCtD
Framycetin—Infection—Diazepam—epilepsy syndrome	0.0017	0.00604	CcSEcCtD
Framycetin—Pruritus—Lacosamide—epilepsy syndrome	0.00168	0.00598	CcSEcCtD
Framycetin—Anaphylactic shock—Felbamate—epilepsy syndrome	0.00165	0.00588	CcSEcCtD
Framycetin—Infection—Felbamate—epilepsy syndrome	0.00164	0.00584	CcSEcCtD
Framycetin—Vomiting—Phenobarbital—epilepsy syndrome	0.00164	0.00583	CcSEcCtD
Framycetin—Pruritus—Clobazam—epilepsy syndrome	0.00163	0.0058	CcSEcCtD
Framycetin—Diarrhoea—Lacosamide—epilepsy syndrome	0.00162	0.00578	CcSEcCtD
Framycetin—Vomiting—Rufinamide—epilepsy syndrome	0.00161	0.00572	CcSEcCtD
Framycetin—Infection—Zonisamide—epilepsy syndrome	0.00161	0.00572	CcSEcCtD
Framycetin—Diarrhoea—Clobazam—epilepsy syndrome	0.00158	0.00561	CcSEcCtD
Framycetin—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.00156	0.00555	CcSEcCtD
Framycetin—Infection—Clonazepam—epilepsy syndrome	0.00155	0.00551	CcSEcCtD
Framycetin—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.00155	0.00551	CcSEcCtD
Framycetin—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.00154	0.00548	CcSEcCtD
Framycetin—Infection—Phenytoin—epilepsy syndrome	0.00154	0.00548	CcSEcCtD
Framycetin—Nausea—Phenobarbital—epilepsy syndrome	0.00153	0.00545	CcSEcCtD
Framycetin—Infection—Oxcarbazepine—epilepsy syndrome	0.00153	0.00545	CcSEcCtD
Framycetin—Vomiting—Lacosamide—epilepsy syndrome	0.00151	0.00537	CcSEcCtD
Framycetin—Nausea—Rufinamide—epilepsy syndrome	0.0015	0.00535	CcSEcCtD
Framycetin—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.00148	0.00526	CcSEcCtD
Framycetin—Infection—Carbamazepine—epilepsy syndrome	0.00147	0.00523	CcSEcCtD
Framycetin—Vomiting—Clobazam—epilepsy syndrome	0.00146	0.00522	CcSEcCtD
Framycetin—Infection—Lamotrigine—epilepsy syndrome	0.00142	0.00505	CcSEcCtD
Framycetin—Nausea—Lacosamide—epilepsy syndrome	0.00141	0.00502	CcSEcCtD
Framycetin—Diarrhoea—Acetazolamide—epilepsy syndrome	0.0014	0.005	CcSEcCtD
Framycetin—Hypersensitivity—Midazolam—epilepsy syndrome	0.00137	0.0049	CcSEcCtD
Framycetin—Nausea—Clobazam—epilepsy syndrome	0.00137	0.00487	CcSEcCtD
Framycetin—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.00136	0.00483	CcSEcCtD
Framycetin—Pruritus—Propofol—epilepsy syndrome	0.00135	0.0048	CcSEcCtD
Framycetin—Pruritus—Midazolam—epilepsy syndrome	0.00132	0.0047	CcSEcCtD
Framycetin—Vomiting—Acetazolamide—epilepsy syndrome	0.00131	0.00465	CcSEcCtD
Framycetin—Diarrhoea—Propofol—epilepsy syndrome	0.0013	0.00465	CcSEcCtD
Framycetin—Pruritus—Levetiracetam—epilepsy syndrome	0.0013	0.00464	CcSEcCtD
Framycetin—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.00128	0.00455	CcSEcCtD
Framycetin—Diarrhoea—Levetiracetam—epilepsy syndrome	0.00126	0.00449	CcSEcCtD
Framycetin—Pruritus—Fosphenytoin—epilepsy syndrome	0.00126	0.00448	CcSEcCtD
Framycetin—Hypersensitivity—Diazepam—epilepsy syndrome	0.00126	0.00448	CcSEcCtD
Framycetin—Pruritus—Vigabatrin—epilepsy syndrome	0.00123	0.00437	CcSEcCtD
Framycetin—Nausea—Acetazolamide—epilepsy syndrome	0.00122	0.00434	CcSEcCtD
Framycetin—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.00122	0.00433	CcSEcCtD
Framycetin—Vomiting—Propofol—epilepsy syndrome	0.00121	0.00432	CcSEcCtD
Framycetin—Pruritus—Diazepam—epilepsy syndrome	0.00121	0.0043	CcSEcCtD
Framycetin—Hypersensitivity—Zonisamide—epilepsy syndrome	0.00119	0.00424	CcSEcCtD
Framycetin—Vomiting—Midazolam—epilepsy syndrome	0.00119	0.00422	CcSEcCtD
Framycetin—Diarrhoea—Vigabatrin—epilepsy syndrome	0.00119	0.00422	CcSEcCtD
Framycetin—Vomiting—Levetiracetam—epilepsy syndrome	0.00117	0.00417	CcSEcCtD
Framycetin—Pruritus—Felbamate—epilepsy syndrome	0.00117	0.00416	CcSEcCtD
Framycetin—Diarrhoea—Diazepam—epilepsy syndrome	0.00117	0.00416	CcSEcCtD
Framycetin—Erythema—Gabapentin—epilepsy syndrome	0.00115	0.0041	CcSEcCtD
Framycetin—Hypersensitivity—Clonazepam—epilepsy syndrome	0.00115	0.00409	CcSEcCtD
Framycetin—Pruritus—Zonisamide—epilepsy syndrome	0.00114	0.00407	CcSEcCtD
Framycetin—Hypersensitivity—Phenytoin—epilepsy syndrome	0.00114	0.00406	CcSEcCtD
Framycetin—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.00113	0.00404	CcSEcCtD
Framycetin—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.00113	0.00404	CcSEcCtD
Framycetin—Nausea—Propofol—epilepsy syndrome	0.00113	0.00403	CcSEcCtD
Framycetin—Vomiting—Fosphenytoin—epilepsy syndrome	0.00113	0.00403	CcSEcCtD
Framycetin—Diarrhoea—Felbamate—epilepsy syndrome	0.00113	0.00402	CcSEcCtD
Framycetin—Infection—Valproic Acid—epilepsy syndrome	0.00113	0.00401	CcSEcCtD
Framycetin—Nausea—Midazolam—epilepsy syndrome	0.00111	0.00395	CcSEcCtD
Framycetin—Diarrhoea—Zonisamide—epilepsy syndrome	0.00111	0.00394	CcSEcCtD
Framycetin—Pruritus—Clonazepam—epilepsy syndrome	0.0011	0.00393	CcSEcCtD
Framycetin—Vomiting—Vigabatrin—epilepsy syndrome	0.0011	0.00392	CcSEcCtD
Framycetin—Pruritus—Phenytoin—epilepsy syndrome	0.00109	0.0039	CcSEcCtD
Framycetin—Nausea—Levetiracetam—epilepsy syndrome	0.00109	0.0039	CcSEcCtD
Framycetin—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00109	0.00388	CcSEcCtD
Framycetin—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.00109	0.00388	CcSEcCtD
Framycetin—Vomiting—Diazepam—epilepsy syndrome	0.00108	0.00386	CcSEcCtD
Framycetin—Diarrhoea—Clonazepam—epilepsy syndrome	0.00107	0.0038	CcSEcCtD
Framycetin—Diarrhoea—Phenytoin—epilepsy syndrome	0.00106	0.00377	CcSEcCtD
Framycetin—Nausea—Fosphenytoin—epilepsy syndrome	0.00106	0.00376	CcSEcCtD
Framycetin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.00105	0.00375	CcSEcCtD
Framycetin—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.00105	0.00375	CcSEcCtD
Framycetin—Vomiting—Felbamate—epilepsy syndrome	0.00105	0.00374	CcSEcCtD
Framycetin—Pruritus—Carbamazepine—epilepsy syndrome	0.00105	0.00372	CcSEcCtD
Framycetin—Nausea—Vigabatrin—epilepsy syndrome	0.00103	0.00367	CcSEcCtD
Framycetin—Vomiting—Zonisamide—epilepsy syndrome	0.00103	0.00366	CcSEcCtD
Framycetin—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.00103	0.00365	CcSEcCtD
Framycetin—Infection—Pregabalin—epilepsy syndrome	0.00102	0.00363	CcSEcCtD
Framycetin—Nausea—Diazepam—epilepsy syndrome	0.00101	0.00361	CcSEcCtD
Framycetin—Diarrhoea—Carbamazepine—epilepsy syndrome	0.00101	0.0036	CcSEcCtD
Framycetin—Pruritus—Lamotrigine—epilepsy syndrome	0.00101	0.0036	CcSEcCtD
Framycetin—Vomiting—Clonazepam—epilepsy syndrome	0.000991	0.00353	CcSEcCtD
Framycetin—Vomiting—Phenytoin—epilepsy syndrome	0.000984	0.0035	CcSEcCtD
Framycetin—Nausea—Felbamate—epilepsy syndrome	0.000981	0.00349	CcSEcCtD
Framycetin—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000979	0.00349	CcSEcCtD
Framycetin—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000977	0.00348	CcSEcCtD
Framycetin—Erythema—Topiramate—epilepsy syndrome	0.000969	0.00345	CcSEcCtD
Framycetin—Nausea—Zonisamide—epilepsy syndrome	0.00096	0.00342	CcSEcCtD
Framycetin—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.00094	0.00335	CcSEcCtD
Framycetin—Vomiting—Carbamazepine—epilepsy syndrome	0.000939	0.00334	CcSEcCtD
Framycetin—Infection—Gabapentin—epilepsy syndrome	0.000934	0.00333	CcSEcCtD
Framycetin—Nausea—Clonazepam—epilepsy syndrome	0.000925	0.0033	CcSEcCtD
Framycetin—Nausea—Phenytoin—epilepsy syndrome	0.000919	0.00327	CcSEcCtD
Framycetin—Nausea—Oxcarbazepine—epilepsy syndrome	0.000914	0.00326	CcSEcCtD
Framycetin—Vomiting—Lamotrigine—epilepsy syndrome	0.000908	0.00323	CcSEcCtD
Framycetin—Nausea—Carbamazepine—epilepsy syndrome	0.000877	0.00312	CcSEcCtD
Framycetin—Nausea—Lamotrigine—epilepsy syndrome	0.000848	0.00302	CcSEcCtD
Framycetin—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000836	0.00298	CcSEcCtD
Framycetin—Pruritus—Valproic Acid—epilepsy syndrome	0.000803	0.00286	CcSEcCtD
Framycetin—Infection—Topiramate—epilepsy syndrome	0.000786	0.0028	CcSEcCtD
Framycetin—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000776	0.00276	CcSEcCtD
Framycetin—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000756	0.00269	CcSEcCtD
Framycetin—Pruritus—Pregabalin—epilepsy syndrome	0.000726	0.00258	CcSEcCtD
Framycetin—Vomiting—Valproic Acid—epilepsy syndrome	0.000721	0.00257	CcSEcCtD
Framycetin—Diarrhoea—Pregabalin—epilepsy syndrome	0.000702	0.0025	CcSEcCtD
Framycetin—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000693	0.00247	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CRH—epilepsy syndrome	0.000683	0.0011	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL2—epilepsy syndrome	0.000683	0.0011	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCL3—epilepsy syndrome	0.000683	0.0011	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—OXT—epilepsy syndrome	0.000683	0.0011	CbGpPWpGaD
Framycetin—Nausea—Valproic Acid—epilepsy syndrome	0.000674	0.0024	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—GRM2—epilepsy syndrome	0.000668	0.00108	CbGpPWpGaD
Framycetin—Pruritus—Gabapentin—epilepsy syndrome	0.000665	0.00237	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—SSTR3—epilepsy syndrome	0.000665	0.00107	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CCR5—epilepsy syndrome	0.000658	0.00106	CbGpPWpGaD
Framycetin—Vomiting—Pregabalin—epilepsy syndrome	0.000652	0.00232	CcSEcCtD
Framycetin—CXCR4—Disease—STX1B—epilepsy syndrome	0.000644	0.00104	CbGpPWpGaD
Framycetin—Diarrhoea—Gabapentin—epilepsy syndrome	0.000643	0.00229	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—CCR8—epilepsy syndrome	0.000638	0.00103	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—SSTR1—epilepsy syndrome	0.000638	0.00103	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCR9—epilepsy syndrome	0.000638	0.00103	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—NPY2R—epilepsy syndrome	0.000638	0.00103	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	0.000638	0.00103	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GRM4—epilepsy syndrome	0.000625	0.00101	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GRM3—epilepsy syndrome	0.000625	0.00101	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCR2—epilepsy syndrome	0.000618	0.000997	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—SST—epilepsy syndrome	0.000618	0.000997	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.000615	0.000992	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—SSTR2—epilepsy syndrome	0.000614	0.00099	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—AGT—epilepsy syndrome	0.000611	0.000985	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	0.00061	0.000985	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—POMC—epilepsy syndrome	0.000609	0.000983	CbGpPWpGaD
Framycetin—Nausea—Pregabalin—epilepsy syndrome	0.000609	0.00217	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.000605	0.000976	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—SSTR3—epilepsy syndrome	0.000604	0.000974	CbGpPWpGaD
Framycetin—CXCR4—Disease—GBE1—epilepsy syndrome	0.000599	0.000966	CbGpPWpGaD
Framycetin—CXCR4—Disease—CPSF4—epilepsy syndrome	0.000599	0.000966	CbGpPWpGaD
Framycetin—CXCR4—Disease—PPP1R3C—epilepsy syndrome	0.000599	0.000966	CbGpPWpGaD
Framycetin—Vomiting—Gabapentin—epilepsy syndrome	0.000598	0.00213	CcSEcCtD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	0.000597	0.000964	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL2—epilepsy syndrome	0.000596	0.000962	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000595	0.00096	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRDM4—epilepsy syndrome	0.000595	0.00096	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GRM8—epilepsy syndrome	0.000593	0.000956	CbGpPWpGaD
Framycetin—Hypersensitivity—Topiramate—epilepsy syndrome	0.000583	0.00208	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.000581	0.000937	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL12—epilepsy syndrome	0.000581	0.000937	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.000579	0.000934	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCR9—epilepsy syndrome	0.000579	0.000934	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—NPY2R—epilepsy syndrome	0.000579	0.000934	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCR8—epilepsy syndrome	0.000579	0.000934	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—SSTR1—epilepsy syndrome	0.000579	0.000934	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CNR1—epilepsy syndrome	0.00057	0.00092	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	0.000569	0.000918	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GRM3—epilepsy syndrome	0.000568	0.000916	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GRM4—epilepsy syndrome	0.000568	0.000916	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—OPRD1—epilepsy syndrome	0.000565	0.000912	CbGpPWpGaD
Framycetin—Pruritus—Topiramate—epilepsy syndrome	0.00056	0.00199	CcSEcCtD
Framycetin—Nausea—Gabapentin—epilepsy syndrome	0.000559	0.00199	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—SSTR2—epilepsy syndrome	0.000557	0.000899	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—HTR7—epilepsy syndrome	0.000557	0.000898	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PDYN—epilepsy syndrome	0.000542	0.000874	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GRM1—epilepsy syndrome	0.000542	0.000874	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCR7—epilepsy syndrome	0.000542	0.000874	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.000542	0.000874	CbGpPWpGaD
Framycetin—Diarrhoea—Topiramate—epilepsy syndrome	0.000541	0.00193	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—GRM8—epilepsy syndrome	0.000538	0.000868	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.000523	0.000844	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ACKR4—epilepsy syndrome	0.00052	0.00084	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—POMC—epilepsy syndrome	0.000514	0.000829	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000513	0.000828	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000513	0.000828	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.000512	0.000826	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GAL—epilepsy syndrome	0.00051	0.000822	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GRM5—epilepsy syndrome	0.000504	0.000813	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.000504	0.000813	CbGpPWpGaD
Framycetin—Vomiting—Topiramate—epilepsy syndrome	0.000503	0.00179	CcSEcCtD
Framycetin—CXCR4—Disease—ST3GAL3—epilepsy syndrome	0.000498	0.000804	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PDYN—epilepsy syndrome	0.000492	0.000794	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CHRM1—epilepsy syndrome	0.000492	0.000794	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GRM1—epilepsy syndrome	0.000492	0.000794	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCR7—epilepsy syndrome	0.000492	0.000794	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.000486	0.000783	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.000474	0.000764	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.000474	0.000764	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SSTR4—epilepsy syndrome	0.000471	0.000759	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SSTR5—epilepsy syndrome	0.000471	0.000759	CbGpPWpGaD
Framycetin—Nausea—Topiramate—epilepsy syndrome	0.00047	0.00167	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—AKT1—epilepsy syndrome	0.000469	0.000757	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—AVP—epilepsy syndrome	0.000468	0.000756	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GAL—epilepsy syndrome	0.000463	0.000747	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000461	0.000743	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GRM5—epilepsy syndrome	0.000458	0.000738	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000458	0.000738	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR10—epilepsy syndrome	0.000451	0.000728	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000442	0.000713	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000439	0.000708	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000435	0.000702	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.00043	0.000694	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CHRM2—epilepsy syndrome	0.00043	0.000694	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.00043	0.000694	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000419	0.000675	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000411	0.000663	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000409	0.000659	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HRH3—epilepsy syndrome	0.000401	0.000647	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—NPY—epilepsy syndrome	0.0004	0.000646	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.0004	0.000645	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCR5—epilepsy syndrome	0.000398	0.000642	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000395	0.000637	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRM2—epilepsy syndrome	0.000394	0.000636	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—HTR2A—epilepsy syndrome	0.00039	0.000629	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CRH—epilepsy syndrome	0.000386	0.000623	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000386	0.000623	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—OXT—epilepsy syndrome	0.000386	0.000623	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCR3—epilepsy syndrome	0.000373	0.000602	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—AGT—epilepsy syndrome	0.00037	0.000597	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—NPY—epilepsy syndrome	0.000364	0.000586	CbGpPWpGaD
Framycetin—CXCR4—Disease—EIF2AK2—epilepsy syndrome	0.000363	0.000585	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SSTR3—epilepsy syndrome	0.000357	0.000575	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CRH—epilepsy syndrome	0.000351	0.000566	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL3—epilepsy syndrome	0.000351	0.000566	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000351	0.000566	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—OXT—epilepsy syndrome	0.000351	0.000566	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—SST—epilepsy syndrome	0.000349	0.000563	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000349	0.000563	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000349	0.000563	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR9—epilepsy syndrome	0.000342	0.000552	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR8—epilepsy syndrome	0.000342	0.000552	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SSTR1—epilepsy syndrome	0.000342	0.000552	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000342	0.000552	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NPY2R—epilepsy syndrome	0.000342	0.000552	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000342	0.000551	CbGpPWpGaD
Framycetin—CXCR4—Disease—PPIA—epilepsy syndrome	0.000336	0.000542	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRM3—epilepsy syndrome	0.000335	0.000541	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRM4—epilepsy syndrome	0.000335	0.000541	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—DUSP4—epilepsy syndrome	0.000329	0.000531	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SSTR2—epilepsy syndrome	0.000329	0.000531	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000328	0.00053	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000328	0.00053	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000322	0.00052	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000321	0.000518	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRM8—epilepsy syndrome	0.000318	0.000513	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PGF—epilepsy syndrome	0.000318	0.000513	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—SST—epilepsy syndrome	0.000317	0.000512	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCR2—epilepsy syndrome	0.000317	0.000512	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000315	0.000507	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—POMC—epilepsy syndrome	0.000311	0.000502	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.00031	0.000501	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCL2—epilepsy syndrome	0.000305	0.000491	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—OPRD1—epilepsy syndrome	0.000303	0.000489	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GNAO1—epilepsy syndrome	0.000303	0.000489	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT3—epilepsy syndrome	0.0003	0.000483	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000298	0.000481	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000298	0.000481	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CNR1—epilepsy syndrome	0.000293	0.000472	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000292	0.00047	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CHRM1—epilepsy syndrome	0.000291	0.000469	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDYN—epilepsy syndrome	0.000291	0.000469	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRM1—epilepsy syndrome	0.000291	0.000469	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR7—epilepsy syndrome	0.000291	0.000469	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HTR7—epilepsy syndrome	0.000286	0.000461	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000277	0.000447	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000273	0.000441	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GFAP—epilepsy syndrome	0.000273	0.000441	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GAL—epilepsy syndrome	0.000273	0.000441	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT3—epilepsy syndrome	0.000272	0.000439	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CHRM3—epilepsy syndrome	0.00027	0.000436	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASP2—epilepsy syndrome	0.00027	0.000436	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRM5—epilepsy syndrome	0.00027	0.000436	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AVP—epilepsy syndrome	0.000265	0.000427	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000259	0.000418	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CHRM2—epilepsy syndrome	0.000254	0.00041	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000254	0.00041	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000254	0.00041	CbGpPWpGaD
Framycetin—CXCR4—Disease—SLC2A1—epilepsy syndrome	0.000249	0.000401	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CDC42—epilepsy syndrome	0.000248	0.000401	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GABBR1—epilepsy syndrome	0.000247	0.000399	CbGpPWpGaD
Framycetin—CXCR4—Disease—JUNB—epilepsy syndrome	0.000247	0.000398	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS1—epilepsy syndrome	0.000245	0.000395	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AVP—epilepsy syndrome	0.00024	0.000388	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HRH3—epilepsy syndrome	0.000237	0.000382	CbGpPWpGaD
Framycetin—CXCR4—Disease—HBEGF—epilepsy syndrome	0.000234	0.000377	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—OPRM1—epilepsy syndrome	0.000233	0.000376	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT3—epilepsy syndrome	0.00023	0.00037	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000225	0.000363	CbGpPWpGaD
Framycetin—CXCR4—Disease—ADAM10—epilepsy syndrome	0.000224	0.000362	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR3—epilepsy syndrome	0.00022	0.000355	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.00022	0.000355	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NPY—epilepsy syndrome	0.000215	0.000346	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000215	0.000346	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDC42—epilepsy syndrome	0.000209	0.000338	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AGT—epilepsy syndrome	0.000209	0.000337	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HSPB1—epilepsy syndrome	0.000207	0.000334	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL2—epilepsy syndrome	0.000207	0.000334	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL3—epilepsy syndrome	0.000207	0.000334	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—OXT—epilepsy syndrome	0.000207	0.000334	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CRH—epilepsy syndrome	0.000207	0.000334	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCR5—epilepsy syndrome	0.000204	0.00033	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HTR2A—epilepsy syndrome	0.0002	0.000323	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000193	0.000312	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TSC1—epilepsy syndrome	0.000193	0.000311	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTK2B—epilepsy syndrome	0.000193	0.000311	CbGpPWpGaD
Framycetin—CXCR4—Disease—HES1—epilepsy syndrome	0.000192	0.000309	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AGT—epilepsy syndrome	0.00019	0.000306	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR2—epilepsy syndrome	0.000187	0.000302	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NTRK2—epilepsy syndrome	0.000187	0.000302	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SST—epilepsy syndrome	0.000187	0.000302	CbGpPWpGaD
Framycetin—CXCR4—Disease—FYN—epilepsy syndrome	0.000186	0.000301	CbGpPWpGaD
Framycetin—CXCR4—Disease—H2AFX—epilepsy syndrome	0.000186	0.0003	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—DUSP6—epilepsy syndrome	0.000186	0.0003	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000183	0.000296	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PLAT—epilepsy syndrome	0.000183	0.000295	CbGpPWpGaD
Framycetin—CXCR4—Disease—YWHAZ—epilepsy syndrome	0.000179	0.000289	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000176	0.000284	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL12—epilepsy syndrome	0.000176	0.000284	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—POMC—epilepsy syndrome	0.000176	0.000284	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000175	0.000283	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000175	0.000282	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JUNB—epilepsy syndrome	0.000173	0.000279	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CNR1—epilepsy syndrome	0.000173	0.000279	CbGpPWpGaD
Framycetin—CXCR4—Disease—CCR5—epilepsy syndrome	0.000172	0.000278	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PLCB1—epilepsy syndrome	0.000172	0.000278	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HTR7—epilepsy syndrome	0.000169	0.000272	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HBEGF—epilepsy syndrome	0.000164	0.000264	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT3—epilepsy syndrome	0.000161	0.000259	CbGpPWpGaD
Framycetin—CXCR4—Disease—TSC2—epilepsy syndrome	0.00016	0.000259	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—POMC—epilepsy syndrome	0.00016	0.000258	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADAM10—epilepsy syndrome	0.000157	0.000253	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOE—epilepsy syndrome	0.000157	0.000253	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL2—epilepsy syndrome	0.000156	0.000252	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—S100B—epilepsy syndrome	0.000148	0.00024	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6ST—epilepsy syndrome	0.000147	0.000238	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SOCS3—epilepsy syndrome	0.000147	0.000237	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDC42—epilepsy syndrome	0.000147	0.000237	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS2—epilepsy syndrome	0.000146	0.000236	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AVP—epilepsy syndrome	0.000142	0.000229	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HES1—epilepsy syndrome	0.000134	0.000217	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FYN—epilepsy syndrome	0.000131	0.000211	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—H2AFX—epilepsy syndrome	0.00013	0.00021	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MEF2C—epilepsy syndrome	0.00013	0.00021	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000126	0.000202	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NGF—epilepsy syndrome	0.000124	0.0002	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR5—epilepsy syndrome	0.000121	0.000195	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGF2—epilepsy syndrome	0.000119	0.000192	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HTR2A—epilepsy syndrome	0.000118	0.000191	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TSC2—epilepsy syndrome	0.000112	0.000181	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AGT—epilepsy syndrome	0.000112	0.000181	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APOE—epilepsy syndrome	0.00011	0.000177	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTOR—epilepsy syndrome	0.000108	0.000175	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KDR—epilepsy syndrome	0.000108	0.000174	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTGS2—epilepsy syndrome	0.000107	0.000173	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKCB—epilepsy syndrome	0.000104	0.000167	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6ST—epilepsy syndrome	0.000103	0.000166	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—POMC—epilepsy syndrome	9.44e-05	0.000152	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL2—epilepsy syndrome	9.23e-05	0.000149	CbGpPWpGaD
Framycetin—CXCR4—Disease—SRC—epilepsy syndrome	8.69e-05	0.00014	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGF2—epilepsy syndrome	8.34e-05	0.000135	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RELA—epilepsy syndrome	7.75e-05	0.000125	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MTOR—epilepsy syndrome	7.6e-05	0.000123	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT1—epilepsy syndrome	7.05e-05	0.000114	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASP3—epilepsy syndrome	6.99e-05	0.000113	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JUN—epilepsy syndrome	6.79e-05	0.000109	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP9—epilepsy syndrome	6.6e-05	0.000107	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT1—epilepsy syndrome	6.4e-05	0.000103	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SRC—epilepsy syndrome	6.09e-05	9.82e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—epilepsy syndrome	5.93e-05	9.56e-05	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT1—epilepsy syndrome	5.4e-05	8.71e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT1—epilepsy syndrome	3.78e-05	6.1e-05	CbGpPWpGaD
